The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Delorean Corporation (DEL) raises $1.63 million from its share purchase plan (SPP) to underpin future growth
  • A total of 9.57 million new shares will be issued at the same price as the placement of 17 cents
  • The SPP was originally designed to raise $2 million, but the company said it has no intention to place any further shares
  • Shares are trading flat today 16.5 cents each

Renewable energy and waste management company, Delorean Corporation (DEL) has raised $1.63 million from its share purchase plan (SPP) to underpin future growth.

A total of 9.57 million new shares will be issued at the same price as a recent placement of 17 cents.

The SPP was originally designed to raise $2 million, but the company said it has no intention to place any further shares.

The funds will be directed towards a number of activities, including cash back performance bonds for engineer procure and construct contracts.

It will also be used to develop a forward contracting strategy in relation to Large Scale Generation certificates.

Finally, the money will assist with working capital and continued development of the company’s bioenergy infrastructure project pipeline.

Shares were trading flat today 16.5 cents each at 3:16 pm AEST.

DEL by the numbers
More From The Market Online
Tariff concept

Week 14 Wrap: Tariffs tank markets as expected; will Rio Tinto ditch LSE?; EU ETFs soar

Let's start with the obvious one: Trump's wave of "Liberation Day" tariffs have finally come, and…
The Market Online Video

HotCopper Highlights for Week 14 – Mesoblast, Cettire, Neurizon & more!

Good Afternoon and welcome to this edition of HotCopper Highlights, I’m Jonathon Davidson. Let's get into…
Flag of Spain

Elementos publishes robust DFS for Oropesa tin project

Elementos Ltd has seen its shares rise more than 2% following its release of a definitive…
The Market Online Video

Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025

The ASX has been down 1.5% at 7,739 points this morning.